Dysphagia in Head and Neck Cancer With Radiation
The Impact of Swallowing and Nutrition in Head and Neck Cancer Patients Undergoing Chemo or Chemo-radiotherapy.
1 other identifier
observational
50
0 countries
N/A
Brief Summary
This study focuses on swallowing dysfunction, a common issue affecting 60-75% of head and neck cancer patients due to tumor damage, treatment complications, and chemoradiotherapy side effects, which can lead to malnutrition and reduced quality of life. With limited research on the effects of radiation doses on swallowing muscles and nutrition, this study aims to evaluate these impacts in non-surgical patients undergoing radiotherapy, conducting assessments before treatment, three months after, and within one year post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2024
CompletedFirst Posted
Study publicly available on registry
December 24, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2031
December 24, 2024
December 1, 2024
6 years
December 15, 2024
December 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hypopharyngeal mean peak pressure
hypopharyngeal contraction
one year
Study Arms (1)
head and neck cancer patients
patients with head and neck cancer undergoing radiation therapy
Eligibility Criteria
patients with head and neck cancer undergoing radiation therapy
You may qualify if:
- Patients scheduled to undergo radiotherapy or concurrent chemoradiotherapy ;
- Aged between 18 and 80 years;
- Able to perform self-care independently (ECOG ≤ 2);
- All patients provide written informed consent.
You may not qualify if:
- Patients scheduled to undergo surgical treatment;
- Patients with neuromuscular diseases, such as stroke or Parkinson's disease;
- Patients with other diseases or complications, including heart disease classified as NYHA functional class ≥ 2 with thrombotic conditions, or lung disease classified as Hugh-Jones grade ≥ 4;
- Patients with psychological disorders that may affect their ability to provide informed consent or comply with the study protocol;
- Patients who do not consent to undergo high-resolution impedance manometry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
the DNA associated with nutrition
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Anesthesiologist
Study Record Dates
First Submitted
December 15, 2024
First Posted
December 24, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2031
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
due to ethical issue